Abstract
Stratification of clinical N2 disease by the number of stations involved can reduce prognostic heterogeneity by identifying the two patient groups with different prognoses. Background Patients with N1 or N2 non–small cell lung cancer exhibit prognostic heterogeneity. To refine the current N staging system, new N stages were proposed by the International Association fo...
Funding Information
  • National Research Foundation of Korea (2019R1F1A1058261)
  • Seoul National University Bundang Hospital (02-2019-020)

This publication has 25 references indexed in Scilit: